Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas

被引：121

作者：

Kataoka, Keisuke ^{[1
,2
]}

Miyoshi, Hiroaki ^{[3
]}

Sakata, Seiji ^{[4
]}

Dobashi, Akito ^{[4
]}

Couronne, Lucile ^{[5
,6
,7
,8
]}

Kogure, Yasunori ^{[13
]}

Sato, Yasuharu ^{[9
,10
]}

Nishida, Kenji ^{[9
]}

Gion, Yuka ^{[9
]}

Shiraishi, Yuichi ^{[11
]}

Tanaka, Hiroko ^{[11
]}

Chiba, Kenichi ^{[11
]}

Watatani, Yosaku ^{[1
]}

Kakiuchi, Nobuyuki ^{[1
]}

Shiozawa, Yusuke ^{[1
]}

Yoshizato, Tetsuichi ^{[1
]}

Yoshida, Kenichi ^{[1
]}

Makishima, Hideki ^{[1
]}

Sanada, Masashi ^{[12
]}

Onozawa, Masahiro ^{[13
]}

Teshima, Takanori ^{[13
]}

Yoshiki, Yumiko ^{[14
]}

Ishida, Tadao ^{[14
]}

Suzuki, Kenshi ^{[14
]}

Shimada, Kazuyuki ^{[15
]}

Tomita, Akihiro ^{[15
]}

Kato, Motohiro ^{[16
]}

Ota, Yasunori ^{[17
]}

Izutsu, Koji ^{[18
]}

Demachi-Okamura, Ayako ^{[19
]}

Akatsuka, Yoshiki ^{[19
,20
]}

Miyano, Satoru ^{[11
]}

Yoshino, Tadashi ^{[9
]}

Gaulard, Philippe ^{[21
,22
,23
]}

Hermine, Olivier ^{[5
,6
,7
,8
]}

Takeuchi, Kengo ^{[4
]}

Ohshima, Koichi ^{[3
]}

Ogawa, Seishi ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan

[2] Natl Canc Ctr, Div Mol Oncol, Res Inst, Tokyo, Japan

[3] Kurume Univ, Dept Pathol, Sch Med, Kurume, Fukuoka, Japan

[4] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo, Japan

[5] Hop Necker Enfants Malad, AP HP, Dept Hematol, Paris, France

[6] INSERM, UMR 1163, Paris, France

[7] CNRS, ERL 8254, Lab Cellular & Mol Mech Hematol Disorders & Thera, Imagine Inst, Paris, France

[8] Paris Descartes Sorbonne Paris Cite Univ, Paris, France

[9] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan

[10] Okayama Univ, Div Pathophysiol, Grad Sch Hlth Sci, Okayama, Japan

[11] Univ Tokyo, Lab DNA Informat Anal, Ctr Human Genome, Inst Med Sci, Tokyo, Japan

[12] Nagoya Med Ctr, Dept Adv Diag, Clin Res Ctr, Nagoya, Aichi, Japan

[13] Hokkaido Univ, Dept Hematol, Fac Med, Sapporo, Hokkaido, Japan

[14] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan

[15] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Nagoya, Aichi, Japan

[16] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan

[17] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan

[18] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[19] Aichi Canc Ctr, Div Immunol, Res Inst, Nagoya, Aichi, Japan

[20] Fujita Hlth Univ, Dept Hematol, Sch Med, Toyoake, Aichi, Japan

[21] Henri Mondor Hosp, AP HP, Dept Pathol, Creteil, France

[22] Inst Mondor Rech Biomed, INSERM, U955, Equipe 9, Creteil, France

[23] Paris Est Univ, Creteil, France

来源：

LEUKEMIA | 2019年 / 33卷 / 07期

关键词：

B-CELL LYMPHOMA; CLASSICAL HODGKIN LYMPHOMA; IMMUNE CHECKPOINT BLOCKADE; GENETIC ALTERATIONS; SOMATIC MUTATIONS; RECURRENT; PD-L1; REARRANGEMENTS; PEMBROLIZUMAB; EXPRESSION;

D O I：

10.1038/s41375-019-0380-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Viral infection induces potent cellular immunity and activated intracellular signaling, which may dictate the driver events involved in immune escape and clonal selection of virus-associated cancers, including Epstein-Barr virus (EBV)-positive lymphomas. Here, we thoroughly interrogated PD-L1/PD-L2-involving somatic aberrations in 384 samples from various lymphoma subtypes using high-throughput sequencing, particularly focusing on virus-associated lymphomas. A high frequency of PD-L1/PD-L2-involving genetic aberrations was observed in EBV-positive lymphomas [33 (22%) of 148 cases], including extranodal NK/T-cell lymphoma (ENKTL, 23%), aggressive NK-cell leukemia (57%), systemic EBV-positive T-cell lymphoproliferative disorder (17%) as well as EBV-positive diffuse large B-cell lymphoma (DLBCL, 19%) and peripheral T-cell lymphoma-not otherwise specified (15%). Predominantly causing a truncation of the 3'-untranslated region, these alterations represented the most prevalent somatic lesions in ENKTL. By contrast, the frequency was much lower in EBV-negative lymphomas regardless of histology type [12 (5%) of 236 cases]. Besides PD-L1/PD-L2 alterations, EBV-positive DLBCL exhibited a genetic profile distinct from EBV-negative one, characterized by frequent TET2 and DNMT3A mutations and the paucity of CD79B, MYD88, CDKN2A, and FAS alterations. Our findings illustrate unique genetic features of EBV-associated lymphomas, also suggesting a potential role of detecting PD-L1/PD-L2-involving lesions for these lymphomas to be effectively targeted by immune checkpoint blockade.

引用

页码：1687 / 1699

页数：13

共 38 条

[1] Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma [J].

Abate, Francesco ;

Ambrosio, Maria Raffaella ;

Mundo, Lucia ;

Laginestra, Maria Antonella ;

Fuligni, Fabio ;

Rossi, Maura ;

Zairis, Sakellarios ;

Gazaneo, Sara ;

De Falco, Giulia ;

Lazzi, Stefano ;

Bellan, Cristiana ;

Rocca, Bruno Jim ;

Amato, Teresa ;

Marasco, Elena ;

Etebari, Maryam ;

Ogwang, Martin ;

Calbi, Valeria ;

Ndede, Isaac ;

Patel, Kirtika ;

Chumba, David ;

Piccaluga, Pier Paolo ;

Pileri, Stefano ;

Leoncini, Lorenzo ;

Rabadan, Raul .

PLOS PATHOGENS, 2015, 11 (10)

[2] Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas [J].

Afshar-Sterle, Shoukat ;

Zotos, Dimitra ;

Bernard, Nicholas J. ;

Scherger, Anna K. ;

Roedling, Lisa ;

Alsop, Amber E. ;

Walker, Jennifer ;

Masson, Frederick ;

Belz, Gabrielle T. ;

Corcoran, Lynn M. ;

O'Reilly, Lorraine A. ;

Strasser, Andreas ;

Smyth, Mark J. ;

Johnstone, Ricky ;

Tarlinton, David M. ;

Nutt, Stephen L. ;

Kallies, Axel .

NATURE MEDICINE, 2014, 20 (03) :283-290

[3] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[4] Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure [J].

Armand, Philippe ;

Shipp, Margaret A. ;

Ribrag, Vincent ;

Michot, Jean-Marie ;

Zinzani, Pier Luigi ;

Kuruvilla, John ;

Snyder, Ellen S. ;

Ricart, Alejandro D. ;

Balakumaran, Arun ;

Rose, Shelonitda ;

Moskowitz, Craig H. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) :3733-+

[5] HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis [J].

Bagger, Frederik Otzen ;

Rapin, Nicolas ;

Theilgaard-Monch, Kim ;

Kaczkowski, Bogumil ;

Thoren, Lina A. ;

Jendholm, Johan ;

Winther, Ole ;

Porse, Bo T. .

NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) :D1034-D1039

[6] Comprehensive molecular characterization of gastric adenocarcinoma [J].

Bass, Adam J. ;

Thorsson, Vesteinn ;

Shmulevich, Ilya ;

Reynolds, Sheila M. ;

Miller, Michael ;

Bernard, Brady ;

Hinoue, Toshinori ;

Laird, Peter W. ;

Curtis, Christina ;

Shen, Hui ;

Weisenberger, Daniel J. ;

Schultz, Nikolaus ;

Shen, Ronglai ;

Weinhold, Nils ;

Keiser, David P. ;

Bowlby, Reanne ;

Sipahimalani, Payal ;

Cherniack, Andrew D. ;

Getz, Gad ;

Liu, Yingchun ;

Noble, Michael S. ;

Pedamallu, Chandra ;

Sougnez, Carrie ;

Taylor-Weiner, Amaro ;

Akbani, Rehan ;

Lee, Ju-Seog ;

Liu, Wenbin ;

Mills, Gordon B. ;

Yang, Da ;

Zhang, Wei ;

Pantazi, Angeliki ;

Parfenov, Michael ;

Gulley, Margaret ;

Piazuelo, M. Blanca ;

Schneider, Barbara G. ;

Kim, Jihun ;

Boussioutas, Alex ;

Sheth, Margi ;

Demchok, John A. ;

Rabkin, Charles S. ;

Willis, Joseph E. ;

Ng, Sam ;

Garman, Katherine ;

Beer, David G. ;

Pennathur, Arjun ;

Raphael, Benjamin J. ;

Wu, Hsin-Ta ;

Odze, Robert ;

Kim, Hark K. ;

Bowen, Jay .

NATURE, 2014, 513 (7517) :202-209

[7]

Chapuy B, 2015, BLOOD

[8] Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].

Chapuy, Bjoern ;

Stewart, Chip ;

Dunford, Andrew J. ;

Kim, Jaegil ;

Kamburov, Atanas ;

Redd, Robert A. ;

Lawrence, Mike S. ;

Roemer, Margaretha G. M. ;

Li, Amy J. ;

Ziepert, Marita ;

Staiger, Annette M. ;

Wala, Jeremiah A. ;

Ducar, Matthew D. ;

Leshchiner, Ignaty ;

Rheinbay, Ester ;

Taylor-Weiner, Amaro ;

Coughlin, Caroline A. ;

Hess, Julian M. ;

Pedamallu, Chandra S. ;

Livitz, Dimitri ;

Rosebrock, Daniel ;

Rosenberg, Mara ;

Tracy, Adam A. ;

Horn, Heike ;

van Hummelen, Paul ;

Feldman, Andrew L. ;

Link, Brian K. ;

Novak, Anne J. ;

Cerhan, James R. ;

Habermann, Thomas M. ;

Siebert, Reiner ;

Rosenwald, Andreas ;

Thorner, Aaron R. ;

Meyerson, Matthew L. ;

Golub, Todd R. ;

Beroukhim, Rameen ;

Wulf, Gerald G. ;

Ott, German ;

Rodig, Scott J. ;

Monti, Stefano ;

Neuberg, Donna S. ;

Loeffler, Markus ;

Pfreundschuh, Michael ;

Truemper, Lorenz ;

Getz, Gad ;

Shipp, Margaret A. .

NATURE MEDICINE, 2018, 24 (05) :679-+

[9] Genomic landscape of cutaneous T cell lymphoma [J].

Choi, Jaehyuk ;

Goh, Gerald ;

Walradt, Trent ;

Hong, Bok S. ;

Bunick, Christopher G. ;

Chen, Kan ;

Bjornson, Robert D. ;

Maman, Yaakov ;

Wang, Tiffany ;

Tordoff, Jesse ;

Carlson, Kacie ;

Overton, John D. ;

Liu, Kristina J. ;

Lewis, Julia M. ;

Devine, Lesley ;

Barbarotta, Lisa ;

Foss, Francine M. ;

Subtil, Antonio ;

Vonderheid, Eric C. ;

Edelson, Richard L. ;

Schatz, David G. ;

Boggon, Titus J. ;

Girardi, Michael ;

Lifton, Richard P. .

NATURE GENETICS, 2015, 47 (09) :1011-+

[10] Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas [J].

Chong, Lauren C. ;

Twa, David D. W. ;

Mottok, Anja ;

Ben-Neriah, Susana ;

Woolcock, Bruce W. ;

Zhao, Yongjun ;

Savage, Kerry J. ;

Marra, Marco A. ;

Scott, David W. ;

Gascoyne, Randy D. ;

Morin, Ryan D. ;

Mungall, Andrew J. ;

Steidl, Christian .

BLOOD, 2016, 128 (09) :1206-1213

← 1 2 3 4 →